Statement Of Cash Flows [Abstract]
| Concept |
2022-01-01 to 2022-12-31 |
2021-01-01 to 2021-12-31 |
|---|---|---|
| Statement of cash flows [abstract] | ||
| Cash flows from (used in) operating activities [abstract] | ||
| Adjustments for finance income (cost) |
65,000,000
EUR
|
56,000,000
EUR
|
| Cash flows from (used in) operations before changes in working capital |
789,000,000
EUR
|
720,000,000
EUR
|
| Adjustments for decrease (increase) in trade and other receivables |
654,000,000
EUR
|
453,000,000
EUR
|
| Adjustments for increase (decrease) in trade and other payables |
827,000,000
EUR
|
732,000,000
EUR
|
| Adjustments for increase (decrease) in employee benefit liabilities |
10,000,000
EUR
|
10,000,000
EUR
|
| Adjustments for amortisation expense |
104,000,000
EUR
|
106,000,000
EUR
|
| Adjustments for depreciation expense |
351,000,000
EUR
|
352,000,000
EUR
|
| Adjustments for impairment loss (reversal of impairment loss) recognised in profit or loss, trade and other receivables |
34,000,000
EUR
|
2,000,000
EUR
|
| Adjustments for gains (losses) on change in fair value less costs to sell, biological assets |
17,000,000
EUR
|
1,000,000
EUR
|
| Adjustments for undistributed profits of investments accounted for using equity method |
43,000,000
EUR
|
38,000,000
EUR
|
| Income taxes paid, classified as operating activities |
1,000,000
EUR
|
169,000,000
EUR
|
| Cash flows from (used in) investing activities [abstract] | ||
| Dividends received from investments accounted for using equity method, classified as investing activities |
22,000,000
EUR
|
24,000,000
EUR
|
| Proceeds from disposal of non-current assets or disposal groups classified as held for sale and discontinued operations |
-
EUR
|
26,000,000
EUR
|
| Cash flows from (used in) financing activities [abstract] | ||
| Payments for debt issue costs |
1,000,000
EUR
|
1,000,000
EUR
|